Outcomes of prostate cancer screening among men using antidiabetic medication

Diabetic men have decreased risk for prostate cancer (PCa) overall and lower PSA compared to non-diabetics. This may affect the outcomes of PSA-based screening. We investigated the effect of PSA-based screening at 4-year intervals on PCa incidence and mortality separately among users and non-users o...

Descripción completa

Detalles Bibliográficos
Autores principales: Vettenranta, A., Murtola, T. J., Talala, K., Taari, K., Stenman, U.-H., Tammela, T. L. J., Auvinen, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016840/
https://www.ncbi.nlm.nih.gov/pubmed/33795720
http://dx.doi.org/10.1038/s41598-021-86534-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016840/
https://www.ncbi.nlm.nih.gov/pubmed/33795720
http://dx.doi.org/10.1038/s41598-021-86534-2

Ejemplares similares